Skip to main content

Peer Review reports

From: Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis

Original Submission
14 Dec 2024 Submitted Original manuscript
20 Dec 2024 Author responded Author comments - Shiya Ji
Resubmission - Version 2
20 Dec 2024 Submitted Manuscript version 2
31 Dec 2024 Reviewed Reviewer Report
1 Jan 2025 Reviewed Reviewer Report
2 Jan 2025 Reviewed Reviewer Report
2 Jan 2025 Reviewed Reviewer Report - Ebenezer Senu
3 Jan 2025 Reviewed Reviewer Report
19 Jan 2025 Author responded Author comments - Shiya Ji
Resubmission - Version 3
19 Jan 2025 Submitted Manuscript version 3
2 Feb 2025 Reviewed Reviewer Report
2 Feb 2025 Reviewed Reviewer Report
15 Feb 2025 Reviewed Reviewer Report
16 Feb 2025 Reviewed Reviewer Report - Ebenezer Senu
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
17 Feb 2025 Editorially accepted
28 Feb 2025 Article published 10.1186/s12905-025-03612-7

You can find further information about peer review here.

Back to article page